Laboratory of Neurogenomiks
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Clinic Barcelona (11)
2022
-
Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis
Human Molecular Genetics, Vol. 31, Núm. 13, pp. 2155-2163
2016
-
BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year
Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151
2015
-
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis
Human Molecular Genetics, Vol. 24, Núm. 19, pp. 5619-5627
2014
-
Differential neuroprotective effects of 5′-deoxy-5′- methylthioadenosine
PLoS ONE, Vol. 9, Núm. 3
2013
-
A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation
PLoS ONE, Vol. 8, Núm. 12
-
Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis
Journal of Medical Genetics, Vol. 50, Núm. 1, pp. 25-33
2012
-
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci
Genes and Immunity, Vol. 13, Núm. 3, pp. 253-257
2011
-
Gain-of-function of P2X7 receptor gene variants in multiple sclerosis
Cell Calcium, Vol. 50, Núm. 5, pp. 468-472
-
Replication of top markers of a genome-wide association study in multiple sclerosis in Spain
Genes and Immunity, Vol. 12, Núm. 2, pp. 110-115
2010
-
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis
Genes and Immunity, Vol. 11, Núm. 5, pp. 439-445